ワークショップ | Waters at the International Congress of Therapeutic Drug Monitoring & Clinical Toxicology


  • Overview
Date(s): September 25, 2017
Time: 9:40AM - 10:30AM
Location: 国立京都国際会館 スワン
Language: 日本語

ウォーターズは9月25日(月)、ワークショップを開催します。参加ご希望の方は「お申し込みはこちら」よりご登録をお願いします。

 

ワークショップ

Leveraging LC-MS in Therapeutic Drug Monitoring Development

【日時】 9月25日(月) 9:40 am - 10:30 am (50 分)
【会場】 国立京都国際会館 スワン

English
(Please register from the English link if you are not a Japanese)

Expanding the Role of LC-MS/MS in Therapeutic Drug Monitoring (TDM)  

Professor Yusuke Tanigawara,

Keio University School of Medicine, Japan

Modern TDM has grown to cover a diverse selection of drugs ranging from small molecules to biologics.  In this workshop, we will discuss the utility and benefit of LC-MS/MS in the application of TDM.

 

TDM by LC/MS- Single Analyte, Multiplexing and Novel Drugs 

Gareth Hammond, Technical Manager,

Clinical Scientist Operations, Waters Corporation, United Kingdom

This talk will take you through the principles, history and future of TDM using LC-MS/MS technology. Starting at the beginning with the development of the first single analyte immunosuppressant assay for tacrolimus (FK506). The specificity and selectivity of LC-MS/MS can simplify the development of multi-analyte (multiplex) panels, such as anti-depressants, antiepileptics and antifungals. The presentation will conclude with a look to the future and new TDM applications for anti-cancer drugs and the challenges to be addressed and overcome when analysing monoclonal antibodies.

 

Chair: Jose Costro-Prez, Waters Corporation

 

 * IATDMCT では参加登録が必要となります。ご登録は IATDMCT 公式サイト にて受付しています。

 

概要ページへ戻る(英語)